Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Thompson

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Clinical Drug Investigation|October 8, 2022
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) TrialAmber van Broekhoven, Niekbachsh Mohammadnia, Max J M Silvis, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2023
Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formationNisha Schwarz, Sanuja Fernando, Yung-Chih Chen, et al.
Journal of the American College of Cardiology|August 27, 2021
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary SyndromeTjerk S J Opstal, Aernoud T L Fiolet, Amber van Broekhoven, et al.
Cardiovascular Research|August 27, 2024
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarctionPeter J Psaltis, Mau T Nguyen, Kuljit Singh, et al.
European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.
BMJ Open|November 12, 2020
Modification of diet, exercise and lifestyle (MODEL) study: a randomised controlled trial protocolSimone Radavelli-Bagatini, Catherine P Bondonno, Marc Sim, et al.
BMJ Open|November 12, 2020
Implementation, mechanisms of impact and key contextual factors involved in outcomes of the Modification of Diet, Exercise and Lifestyle (MODEL) randomised controlled trial in Australian adults: protocol for a mixed-method process evaluationReindolf Anokye, Simone Radavelli-Bagatini, Catherine P Bondonno, et al.
Nature Communications|October 14, 2024
Impact of provision of abdominal aortic calcification results on fruit and vegetable intake: 12-week randomized phase 2 controlled trialSimone Radavelli-Bagatini, Catherine P Bondonno, Jack Dalla Via, et al.
Eclinicalmedicine|October 21, 2024
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T L Fiolet, Michiel H F Poorthuis, Tjerk S J Opstal, et al.
The New England Journal of Medicine|September 1, 2020
Colchicine in Patients with Chronic Coronary DiseaseStefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Clinical Drug Investigation|October 8, 2022
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) TrialAmber van Broekhoven, Niekbachsh Mohammadnia, Max J M Silvis, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2023
Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formationNisha Schwarz, Sanuja Fernando, Yung-Chih Chen, et al.
Journal of the American College of Cardiology|August 27, 2021
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary SyndromeTjerk S J Opstal, Aernoud T L Fiolet, Amber van Broekhoven, et al.
Cardiovascular Research|August 27, 2024
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarctionPeter J Psaltis, Mau T Nguyen, Kuljit Singh, et al.
European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.
BMJ Open|November 12, 2020
Modification of diet, exercise and lifestyle (MODEL) study: a randomised controlled trial protocolSimone Radavelli-Bagatini, Catherine P Bondonno, Marc Sim, et al.
BMJ Open|November 12, 2020
Implementation, mechanisms of impact and key contextual factors involved in outcomes of the Modification of Diet, Exercise and Lifestyle (MODEL) randomised controlled trial in Australian adults: protocol for a mixed-method process evaluationReindolf Anokye, Simone Radavelli-Bagatini, Catherine P Bondonno, et al.
Nature Communications|October 14, 2024
Impact of provision of abdominal aortic calcification results on fruit and vegetable intake: 12-week randomized phase 2 controlled trialSimone Radavelli-Bagatini, Catherine P Bondonno, Jack Dalla Via, et al.
Eclinicalmedicine|October 21, 2024
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T L Fiolet, Michiel H F Poorthuis, Tjerk S J Opstal, et al.
The New England Journal of Medicine|September 1, 2020
Colchicine in Patients with Chronic Coronary DiseaseStefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, et al.
Pageof 14